Skip to main content

Table 3 Clinical assessment at baseline and 90 days after viscosupplementation

From: Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study

 

Baseline

Day 90

Baseline vs. Day 90

P value

WOMAC Pain

26.0 (7.0–42.0)

16.5 (0.0–46.0)

<0.0001

WOMAC Stiffness

10.0 (0.0–18.0)

6.0 (0.0–17.0)

<0.0001

WOMAC Function

84.0 (23.0–134.0)

58.0 (0.0–133.0)

<0.0001

PGA

7.0 (3.0–10.0)

5.0 (0.0–10.0)

<0.0001

  1. Data are median (range) or percentage of cases. Each WOMAC item was measured on a 11-point Likert scale
  2. PGA, patient global assessment
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us